Connect your AI

Penumbra PEN Loss Contingency Accrual

Loss Contingency Accrual at other companies

MedtronicMDT

——

Boston ScientificBSX

——

Other financials

Income statement

Revenue$374.8M+15.6%

Gross profit$253.4M+17.4%

Operating income$38.2M-5.2%

Net income$32.6M-16.9%

EPS (diluted)$0.82-18.0%

Balance sheet

Cash & equivalents$241.3M-35.8%

Total debt$216.2M-2.0%

Total equity$1.5B+21.5%

Total assets$1.9B+19.2%

Cash flow

Operating cash flow$87.0M+77.6%

CapEx$13.7M+1.5%

Free cash flow$73.3M+106%

Valuation

Market cap$12.48B+25.1%

Enterprise value$12.45B+26.8%

P/E72.9×-163×

P/S8.6×+0.5×

Profitability

Gross margin67.4%+3.7pp

Operating margin12.9%+9.8pp

Net margin11.8%+8.4pp

FCF margin14.6%+2.5pp

Returns & leverage

Return on equity12.7%+9.2pp

Debt / equity0.1×0.0×

Current ratio6×-0.3×

Where this comes from

Reported directly by Penumbra in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.

The official record: Penumbra’s 10-Q, filed October 30, 2024, on SEC EDGAR. View the filing →

Ask your AI about Penumbra's loss contingency accrual.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Penumbra's loss contingency accrual?: Penumbra (PEN) reported loss contingency accrual of $4.6M in Q3 2024.